G — Guanarito Virus
Guanarito virus (GTOV) is an enveloped, single-stranded, negative-sense RNA virus in the family Arenaviridae, genus New World arenavirus. It is one of the causative agents of Venezuelan hemorrhagic fever (VHF), an endemic disease in Venezuela. Like other arenaviruses, GTOV has a bisegmented genome (small S and large L segments) encoding the nucleoprotein (NP), glycoprotein precursor (GPC), RNA-dependent RNA polymerase (L), and matrix protein (Z).
The virus is transmitted to humans primarily through contact with excreta of infected rodent reservoirs (Zygodontomys brevicauda). Human-to-human transmission is rare but can occur via exposure to blood or bodily fluids.
Guanarito virus exhibits high tropism for endothelial cells, monocytes, and dendritic cells. The NP acts as a potent inhibitor of type I interferon signaling, degrading double-stranded RNA intermediates and preventing activation of RIG-I/MDA5 pathways. This allows high-level viral replication and systemic dissemination without early immune control. Endothelial infection, combined with dysregulated host cytokine responses, leads to vascular leak, thrombocytopenia, and hypotension, hallmarks of hemorrhagic fever.
Clinically, infection manifests as fever, malaise, myalgia, and gastrointestinal symptoms, progressing in severe cases to hemorrhage, shock, and multiorgan failure. Mortality rates range from 20–30% in hospitalized patients. Survivors may experience long-term sequelae, but data are limited due to the localized nature of outbreaks.
Research on GTOV focuses on molecular pathogenesis, immune evasion, and vaccine development. Antiviral therapies are currently supportive, but experimental vaccines targeting the viral glycoprotein show promise. Guanarito virus serves as a model for studying New World arenavirus hemorrhagic fevers and the mechanisms of virus-mediated endothelial dysfunction.
Guanarito virus (GTOV) is an enveloped, single-stranded, negative-sense RNA virus in the family Arenaviridae, genus New World arenavirus. It is one of the causative agents of Venezuelan hemorrhagic fever (VHF), an endemic disease in Venezuela. Like other arenaviruses, GTOV has a bisegmented genome (small S and large L segments) encoding the nucleoprotein (NP), glycoprotein precursor (GPC), RNA-dependent RNA polymerase (L), and matrix protein (Z).
The virus is transmitted to humans primarily through contact with excreta of infected rodent reservoirs (Zygodontomys brevicauda). Human-to-human transmission is rare but can occur via exposure to blood or bodily fluids.
Guanarito virus exhibits high tropism for endothelial cells, monocytes, and dendritic cells. The NP acts as a potent inhibitor of type I interferon signaling, degrading double-stranded RNA intermediates and preventing activation of RIG-I/MDA5 pathways. This allows high-level viral replication and systemic dissemination without early immune control. Endothelial infection, combined with dysregulated host cytokine responses, leads to vascular leak, thrombocytopenia, and hypotension, hallmarks of hemorrhagic fever.
Clinically, infection manifests as fever, malaise, myalgia, and gastrointestinal symptoms, progressing in severe cases to hemorrhage, shock, and multiorgan failure. Mortality rates range from 20–30% in hospitalized patients. Survivors may experience long-term sequelae, but data are limited due to the localized nature of outbreaks.
Research on GTOV focuses on molecular pathogenesis, immune evasion, and vaccine development. Antiviral therapies are currently supportive, but experimental vaccines targeting the viral glycoprotein show promise. Guanarito virus serves as a model for studying New World arenavirus hemorrhagic fevers and the mechanisms of virus-mediated endothelial dysfunction.